{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:36:40Z","timestamp":1788482200692,"version":"build-2803163510"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Cancer is a multifaceted disease driven by genetic mutations and epigenetic dysregulation. Among epigenetic modifiers, histone demethylases like KDM4C (lysine demethylase 4C) play a pivotal role in tumor progression by removing repressive methylation mark at Histone H3K9\/H3K36 and altering chromatin structure and gene expression. Overexpression of KDM4C has been implicated in various malignancies, including breast, prostate, colorectal, and hepatocellular carcinomas, hence it is promising drug target. This study employs a structure-based drug discovery strategy to identify natural polyphenolic inhibitors of KDM4C. High-throughput virtual screening, followed by molecular docking, molecular dynamics (MD) simulations, and MM-GBSA free energy calculations, used to assess binding potential. Pectolinarin and compound 202 emerged as top candidates, outperforming the reference ligand (6X9) used from PDBID: 5KR7, in docking scores, and exhibiting robust hydrogen bonding and hydrophobic interactions within the active site. MD simulations over 200 ns confirmed complex stability, indicated by consistently low RMSD and RMSF values. MM-GBSA analysis revealed strong binding affinities with free energy values of \u221268.4 kcal\/mol and \u221265.7 kcal\/mol for Pectolinarin and compound 202, respectively. ADMET predictions supported their drug-likeness, suggesting favorable pharmacokinetic profiles, oral bioavailability, and low toxicity. These findings highlight pectolinarin and compound 202 as promising leads for KDM4C-targeted cancer therapy. Further experimental validation is required to confirm their efficacy and specificity. Overall, this work demonstrates the potential of computational approaches in advancing the discovery of nature-derived epigenetic therapeutics.<\/jats:p>","DOI":"10.1371\/journal.pone.0340107","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T18:32:48Z","timestamp":1767897168000},"page":"e0340107","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Targeting epigenetic regulators: In-silico discovery of natural inhibitors against histone demethylase KDM4C"],"prefix":"10.1371","volume":"21","author":[{"given":"Mukesh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha","family":"P","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumyadip","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subarnarekha","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Phalak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5152-3715","authenticated-orcid":true,"given":"Prakash K.","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"issue":"2","key":"pone.0340107.ref001","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/CEJ.0000000000000842","article-title":"Global trends in anal cancer incidence and mortality","volume":"33","author":"S Mignozzi","year":"2024","journal-title":"Eur J Cancer Prev"},{"key":"pone.0340107.ref002","doi-asserted-by":"crossref","first-page":"9620870","DOI":"10.1155\/2017\/9620870","article-title":"Genetic mutations and epigenetic modifications: driving cancer and informing precision medicine","volume":"2017","author":"KM Coyle","year":"2017","journal-title":"Biomed Res Int"},{"key":"pone.0340107.ref003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2018.03.002","article-title":"Epigenetic control of gene regulation during development and disease: a view from the retina","volume":"65","author":"X Corso-D\u00edaz","year":"2018","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"pone.0340107.ref004","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41698-025-01003-7","article-title":"Epigenetic regulators in cancer therapy and progression","volume":"9","author":"HE Marei","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"pone.0340107.ref005","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/978-3-031-06573-6_12","article-title":"Epigenetic-Mediated Regulation of Gene Expression for Biological Control and Cancer: Cell and Tissue Structure, Function, and Phenotype.","author":"AJ Fritz","year":"2022","journal-title":"Results and Problems in Cell Differentiation. Springer Science and Business Media Deutschland GmbH"},{"issue":"3","key":"pone.0340107.ref006","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/epigenomes6030022","article-title":"Nucleosome structures built from highly divergent histones: parasites and giant DNA viruses","volume":"6","author":"S Sato","year":"2022","journal-title":"Epigenomes"},{"issue":"13","key":"pone.0340107.ref007","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.3390\/ijms22136922","article-title":"Molecular complexes at euchromatin, heterochromatin and centromeric chromatin","volume":"22","author":"O Morrison","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3","key":"pone.0340107.ref008","article-title":"Post-translational modifications of histones: mechanisms, biological functions, and therapeutic targets","volume":"4","author":"R Liu","year":"2023","journal-title":"MedComm (2020)"},{"issue":"4","key":"pone.0340107.ref009","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.molcel.2012.11.006","article-title":"Histone lysine methylation dynamics: establishment, regulation, and biological impact","volume":"48","author":"JC Black","year":"2012","journal-title":"Mol Cell"},{"issue":"1","key":"pone.0340107.ref010","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/14756366.2018.1455676","article-title":"Small molecule KDM4s inhibitors as anti-cancer agents","volume":"33","author":"H Lin","year":"2018","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"4","key":"pone.0340107.ref011","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400682","article-title":"Targeting N-methyl-lysine histone demethylase KDM4 in cancer: natural products inhibitors as a driving force for epigenetic drug discovery","volume":"20","author":"I Cursaro","year":"2025","journal-title":"Chem Med Chem"},{"key":"pone.0340107.ref012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gde.2019.04.013","article-title":"Role of H3K9me3 heterochromatin in cell identity establishment and maintenance","volume":"55","author":"D Nicetto","year":"2019","journal-title":"Curr Opin Genet Dev"},{"issue":"1","key":"pone.0340107.ref013","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41392-023-01341-7","article-title":"Targeting epigenetic regulators to overcome drug resistance in cancers","volume":"8","author":"N Wang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"pone.0340107.ref014","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41420-023-01418-w","article-title":"KDM4C silencing inhibits cell migration and enhances radiosensitivity by inducing CXCL2 transcription in hepatocellular carcinoma","volume":"9","author":"Z Zeng","year":"2023","journal-title":"Cell Death Discov"},{"issue":"1","key":"pone.0340107.ref015","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s40164-024-00570-y","article-title":"CRISPR\/Cas9 technology for advancements in cancer immunotherapy: from uncovering regulatory mechanisms to therapeutic applications","volume":"13","author":"X Feng","year":"2024","journal-title":"Exp Hematol Oncol"},{"key":"pone.0340107.ref016","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4137\/BCBCR.S40182","article-title":"KDM4C activity modulates cell proliferation and chromosome segregation in triple-negative breast cancer","volume":"10","author":"J Garcia","year":"2016","journal-title":"Breast Cancer (Auckl)"},{"issue":"3","key":"pone.0340107.ref017","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/jacsau.2c00651","article-title":"Distinct inhibition modes of new delhi metallo-\u03b2-lactamase-1 revealed by NMR spectroscopy","volume":"3","author":"K Cheng","year":"2023","journal-title":"JACS Au"},{"issue":"3","key":"pone.0340107.ref018","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"International Natural Product Sciences Taskforce,","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"14","key":"pone.0340107.ref019","doi-asserted-by":"crossref","first-page":"9564","DOI":"10.1021\/acs.jmedchem.2c00680","article-title":"Recent Advances with KDM4 Inhibitors and Potential Applications","volume":"65","author":"Q Wu","year":"2022","journal-title":"J Med Chem"},{"issue":"2","key":"pone.0340107.ref020","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1039\/B912993F","article-title":"A miniaturized screen for inhibitors of Jumonji histone demethylases","volume":"6","author":"M Sakurai","year":"2010","journal-title":"Mol Biosyst"},{"issue":"1","key":"pone.0340107.ref021","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12929-022-00812-3","article-title":"Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancer","volume":"29","author":"J-S Liu","year":"2022","journal-title":"J Biomed Sci"},{"issue":"8","key":"pone.0340107.ref022","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1039\/c0cs00203h","article-title":"Inhibition of 2-oxoglutarate dependent oxygenases","volume":"40","author":"NR Rose","year":"2011","journal-title":"Chem Soc Rev"},{"issue":"9","key":"pone.0340107.ref023","article-title":"Toxoflavin produced by Burkholderia gladioli from Lycoris aurea is a new broad-spectrum fungicide","volume":"85","author":"X Li","year":"2019","journal-title":"Appl Environ Microbiol"},{"key":"pone.0340107.ref024","doi-asserted-by":"crossref","first-page":"125328","DOI":"10.1016\/j.ijbiomac.2023.125328","article-title":"Definition of fatty acid transport protein-2 (FATP2) structure facilitates identification of small molecule inhibitors for the treatment of diabetic complications","volume":"244","author":"M Kumar","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"pone.0340107.ref025","doi-asserted-by":"crossref","first-page":"100743","DOI":"10.1016\/j.chphi.2024.100743","article-title":"In silico identification of novel CDK4 inhibitors for retinoblastoma","volume":"9","author":"M kumar","year":"2024","journal-title":"Chem Phys Impact"},{"key":"pone.0340107.ref026","doi-asserted-by":"crossref","first-page":"100835","DOI":"10.1016\/j.chphi.2025.100835","article-title":"Unraveling the genetic landscape of high-risk retinoblastoma through transcriptome profiling","volume":"10","author":"M Kumar","year":"2025","journal-title":"Chemical Physics Impact"},{"issue":"7958","key":"pone.0340107.ref027","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41586-023-05905-z","article-title":"Computational approaches streamlining drug discovery","volume":"616","author":"AV Sadybekov","year":"2023","journal-title":"Nature"},{"issue":"12","key":"pone.0340107.ref028","doi-asserted-by":"crossref","first-page":"166552","DOI":"10.1016\/j.bbadis.2022.166552","article-title":"Novel epigenetic therapeutic strategies and targets in cancer","volume":"1868","author":"Q Babar","year":"2022","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"9","key":"pone.0340107.ref029","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.3390\/molecules24091739","article-title":"Small molecule inhibitors of KDM5 histone demethylases increase the radiosensitivity of breast cancer cells overexpressing JARID1B","volume":"24","author":"S Pippa","year":"2019","journal-title":"Molecules"},{"issue":"3","key":"pone.0340107.ref030","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"GM Sastry","year":"2013","journal-title":"J Comput Aided Mol Des"},{"issue":"11","key":"pone.0340107.ref031","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1021\/acs.jctc.3c00039","article-title":"Development and benchmarking of open force field 2.0.0: the sage small molecule force field","volume":"19","author":"S Boothroyd","year":"2023","journal-title":"J Chem Theory Comput"},{"issue":"1","key":"pone.0340107.ref032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147230","article-title":"Identification of a small molecule inhibitor of RAD52 by structure-based selection","volume":"11","author":"K Sullivan","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"pone.0340107.ref033","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1021\/acs.jcim.4c01708","article-title":"Accurate physics-based prediction of binding affinities of RNA- and DNA-targeting ligands","volume":"65","author":"AM Abramyan","year":"2025","journal-title":"J Chem Inf Model"},{"issue":"8","key":"pone.0340107.ref034","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1021\/acs.jctc.3c00044","article-title":"Epik: pKa and protonation state prediction through machine learning","volume":"19","author":"RC Johnston","year":"2023","journal-title":"J Chem Theory Comput"},{"issue":"3","key":"pone.0340107.ref035","doi-asserted-by":"crossref","DOI":"10.1002\/jcb.70025","article-title":"\u201cExploration of novel anticancerous agents targeting human aurora kinase C\u201d","volume":"126","author":"D Gupta","year":"2025","journal-title":"J Cell Biochem"},{"issue":"7","key":"pone.0340107.ref036","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"TA Halgren","year":"2004","journal-title":"J Med Chem"},{"issue":"21","key":"pone.0340107.ref037","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"RA Friesner","year":"2006","journal-title":"J Med Chem"},{"issue":"14","key":"pone.0340107.ref038","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1021\/acs.jcim.2c00433","article-title":"Molecular dynamics simulations and diversity selection by extended continuous similarity indices","volume":"62","author":"A R\u00e1cz","year":"2022","journal-title":"J Chem Inf Model"},{"issue":"1","key":"pone.0340107.ref039","doi-asserted-by":"crossref","first-page":"10400","DOI":"10.1038\/s41598-018-28546-z","article-title":"Water pharmacophore: designing ligands using molecular dynamics simulations with water","volume":"8","author":"SW Jung","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"pone.0340107.ref040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/prot.10613","article-title":"A hierarchical approach to all-atom protein loop prediction","volume":"55","author":"MP Jacobson","year":"2004","journal-title":"Proteins"},{"issue":"16","key":"pone.0340107.ref041","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1021\/jm060522a","article-title":"Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring","volume":"49","author":"PD Lyne","year":"2006","journal-title":"J Med Chem"},{"issue":"1","key":"pone.0340107.ref042","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1021\/ci300425v","article-title":"MM\/GBSA binding energy prediction on the PDBbind data set: successes, failures, and directions for further improvement","volume":"53","author":"PA Greenidge","year":"2013","journal-title":"J Chem Inf Model"},{"issue":"12","key":"pone.0340107.ref043","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/ar000033j","article-title":"Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models","volume":"33","author":"PA Kollman","year":"2000","journal-title":"Acc Chem Res"},{"issue":"10","key":"pone.0340107.ref044","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1021\/ci5003735","article-title":"Improving docking results via reranking of ensembles of ligand poses in multiple X-ray protein conformations with MM-GBSA","volume":"54","author":"PA Greenidge","year":"2014","journal-title":"J Chem Inf Model"},{"issue":"1","key":"pone.0340107.ref045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"LD Moore","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"pone.0340107.ref046","doi-asserted-by":"crossref","first-page":"13387","DOI":"10.1038\/ncomms13387","article-title":"Reader domain specificity and lysine demethylase-4 family function","volume":"7","author":"Z Su","year":"2016","journal-title":"Nat Commun"},{"issue":"3","key":"pone.0340107.ref047","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1021\/acs.chemrev.6b00801","article-title":"Inhibitors of protein methyltransferases and demethylases","volume":"118","author":"H\u00dc Kaniskan","year":"2018","journal-title":"Chem Rev"},{"issue":"5","key":"pone.0340107.ref048","doi-asserted-by":"crossref","first-page":"558","DOI":"10.2174\/1568009611313050007","article-title":"Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention","volume":"13","author":"X Tian","year":"2013","journal-title":"Curr Cancer Drug Targets"},{"key":"pone.0340107.ref049","doi-asserted-by":"crossref","first-page":"106129","DOI":"10.1016\/j.compbiomed.2022.106129","article-title":"Genomic and structural mechanistic insight to reveal the differential infectivity of omicron and other variants of concern","volume":"150","author":"P Sharma","year":"2022","journal-title":"Comput Biol Med"},{"issue":"20","key":"pone.0340107.ref050","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.jmb.2014.04.008","article-title":"Gene-specific methylation control of H3K9 and H3K36 on neurotrophic BDNF versus astroglial GFAP genes by KDM4A\/C regulates neural stem cell differentiation","volume":"426","author":"A Cascante","year":"2014","journal-title":"J Mol Biol"},{"issue":"10","key":"pone.0340107.ref051","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.neo.2016.08.005","article-title":"KDM4C, a H3K9me3 Histone Demethylase, is Involved in the Maintenance of Human ESCC-Initiating Cells by Epigenetically Enhancing SOX2 Expression","volume":"18","author":"X Yuan","year":"2016","journal-title":"Neoplasia"},{"key":"pone.0340107.ref052","doi-asserted-by":"crossref","first-page":"750315","DOI":"10.3389\/fonc.2021.750315","article-title":"KDM4 Involvement in Breast Cancer and Possible Therapeutic Approaches","volume":"11","author":"B Varghese","year":"2021","journal-title":"Front Oncol"},{"issue":"12","key":"pone.0340107.ref053","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.4161\/15592294.2014.983381","article-title":"Studies on the catalytic domains of multiple JmjC oxygenases using peptide substrates","volume":"9","author":"ST Williams","year":"2014","journal-title":"Epigenetics"},{"issue":"10","key":"pone.0340107.ref054","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1038\/s41596-021-00597-z","article-title":"A practical guide to large-scale docking","volume":"16","author":"BJ Bender","year":"2021","journal-title":"Nat Protoc"},{"issue":"5","key":"pone.0340107.ref055","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"S Genheden","year":"2015","journal-title":"Expert Opin Drug Discov"},{"issue":"3","key":"pone.0340107.ref056","doi-asserted-by":"crossref","first-page":"100192","DOI":"10.1016\/j.mocell.2025.100192","article-title":"Current advances and future directions in targeting histone demethylases for cancer therapy","volume":"48","author":"J-H Shin","year":"2025","journal-title":"Mol Cells"},{"issue":"25","key":"pone.0340107.ref057","doi-asserted-by":"crossref","first-page":"9235","DOI":"10.1073\/pnas.1404303111","article-title":"Chem-seq permits identification of genomic targets of drugs against androgen receptor regulation selected by functional phenotypic screens","volume":"111","author":"C Jin","year":"2014","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0340107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T18:32:57Z","timestamp":1767897177000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0340107"}},"subtitle":[],"editor":[{"given":"Yusuf Oloruntoyin","family":"Ayipo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0340107","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]}}}